Last updated: 11/07/2018 16:55:25
A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate 500mcg BID or 1000mcg BID via Multi-Dose Powder Inhaler or Placebo with Optional Open-Label Fluticasone Propionate 1000mcg BID via Multi-Dose Powder Inhaler in Subjects with Chronic Oral Steroid-Dependent Asthma.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate 500mcg BID or 1000mcg BID via Multi-Dose Powder Inhaler or Placebo with Optional Open-Label Fluticasone Propionate 1000mcg BID via Multi-Dose Powder Inhaler in Subjects with Chronic Oral Steroid-Dependent Asthma.
Trial description: A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate 500mcg BID or 1000mcg BID via Multi-Dose Powder Inhaler or Placebo with Optional Open-Label Fluticasone Propionate 1000mcg BID via Multi-Dose Powder Inhaler in Subjects with Chronic Oral Steroid-Dependent Asthma.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Nelson HS, Busse WW,, deBoisblanc BP., Berger WE., Noonan MJ, Webb R., Wolford JP, Mahajan PS, Hamedani AG, Shah T., Harding SM. Fluticasone Propionate powder: Oral Corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma J. Aller. Clin. Immunol. 1999, Volume 103, 267-75
Medical condition
Asthma
Product
fluticasone propionate
Collaborators
Not applicable
Study date(s)
November 1994 to August 1996
Type
Not applicable
Phase
2
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1996-30-08
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website